Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Capricor Therap (CAPR)

1.76 -0.09 (-4.86%)

02-20 12:13

Open:

1.81

Pre. Close:

1.85

High:

1.8148

Low:

1.7

Volume:

430,926

Market Cap:

45M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.992 - 2.003

2.003 - 2.012

Low:

1.805 - 1.818

1.818 - 1.829

Close:

1.831 - 1.85

1.85 - 1.867

Technical analysis  (as of: 2018-02-20 11:49:07 AM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 2.37     One year: 2.67

Support:

Support1: 1.60    Support2: 1.33

Resistance:

Resistance1: 2.03    Resistance2: 2.29

Pivot:

1.87

Moving Averages:

MA(5): 1.92     MA(20): 1.85

MA(100): 2.04     MA(250): 1.88

MACD:

MACD(12,26): 0.04     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 39.27     %D(3): 49.69

RSI:

RSI(14): 46.90

52-Week:

High: 4.25  Low: 0.63  Change(%): -43.7

Average Vol(K):

3-Month: 62436  10-Days 60920

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CAPR has closed above bottom band by 19.2%. Bollinger Bands are 54.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to CAPR's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 08 Feb 2018 21:56:15 GMT
Interested In The Healthcare Industry? Take A Look At Capricor Therapeutics ...

Tue, 20 Feb 2018 12:33:45 GMT
Vanguard Group Inc is the second biggest holder of Capricor Therapeutics, Inc ...

Mon, 05 Feb 2018 12:11:15 GMT
Capricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT ...

Tue, 20 Feb 2018 03:11:15 GMT
EPS for Capricor Therapeutics, Inc. (CAPR) Expected At $-0.19

Fri, 16 Feb 2018 21:56:15 GMT
Is Capricor Therapeutics Inc's (NASDAQ:CAPR) CEO Paid Enough To Stay Motivated?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

25.71

Shares Float (M)

20.72

% Held by Insiders

% Held by Institutions

18.90

Shares Short (K)

1460

Shares Short Prior Month (K)

1890

Stock Financials

EPS

-0.590

EPS Est. Current Year

-0.700

EPS Est. Next Year

-0.760

EPS Est. Next Quarter

-0.190

Forward EPS

-0.539

Book Value (p.s.)

1263.100

PEG Ratio

Profit Margin

Operating Margin

-403.40

Return on Assets (ttm)

-69.6

Return on Equity (ttm)

682.2

Qtrly Rev. Growth

-58.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.538

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.39

Levered Free Cash Flow (M)

-9.90

atoplab.com

Valuation

P/E

-2.98

P/E Growth Ratio

-0.05

P/BV

P/S

322660480.00

P/CF

-2.76

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-11-21

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.